als reversal stories

ALS Reversal Stories: Inspiring Journeys of Hope and Recovery

By Anthony Martinez
AD

When a neurologist delivers an ALS diagnosis, the conversation usually centers on slowing progression rather than stopping it. So when word spreads that someone regained the ability to walk, returned to work, or came off a ventilator after being told they had amyotrophic lateral sclerosis, those stories travel fast through support groups, social media, and family group chats. ALS reversal stories carry enormous emotional weight, and for good reason: they suggest that the disease's usual one-way trajectory may not be universal.

But not every uplifting anecdote is a documented reversal, and not every documented reversal is a cure. Some are genuine, carefully verified improvements in people with confirmed ALS. Others turn out to be misdiagnosed conditions that were treatable all along. Understanding the difference matters, because it shapes how patients, families, and clinicians think about hope, research, and the next reasonable step.

What an ALS Reversal Actually Means

In medical language, "reversal" is a specific, measurable claim rather than a general feeling of doing better. Researchers at Duke University's ALS clinic, led by Dr. Richard Bedlack, define a reversal as an improvement of at least three points on the ALS Functional Rating Scale-Revised (ALSFRS-R) that is sustained for twelve months or longer, following a period of documented decline. That distinction separates a true reversal from a plateau, where function simply stops deteriorating.

AD
ALS Reversals - Healing ALS
ALS Reversals - Healing ALS
#110 “Role Reversal”
#110 “Role Reversal”
a man pushing a child in a wheel chair with the caption that reads, dad was 10 my dad adopted was 45 i was born with left side mild
a man pushing a child in a wheel chair with the caption that reads, dad was 10 my dad adopted was 45 i was born with left side mild

The definition exists to protect against wishful thinking. A patient who has a good week, sleeps better, or feels stronger after starting a new supplement has not necessarily reversed anything. Documented reversals require objective evidence gathered over time by clinicians who are actively looking for reasons the improvement might not be real.

The Clinical Definition Behind the Headlines

The ALSFRS-R is a twelve-question scale that scores speech, salivation, swallowing, handwriting, cutting food, dressing, turning in bed, walking, climbing stairs, breathing, and two additional respiratory measures. A perfect score is 48, and patients typically lose roughly one point per month during active disease. Three points is therefore a meaningful amount of function, equivalent to regaining the ability to feed yourself independently or walk without a cane.

Emily and Bryson: Lissencephaly
Emily and Bryson: Lissencephaly
‘Something was seriously wrong with our daughter’s eyes. They were mostly pupil!’: After ‘normal, healthy’ pregnancy, mom receives Axenfeld-Rieger diagnosis
‘Something was seriously wrong with our daughter’s eyes. They were mostly pupil!’: After ‘normal, healthy’ pregnancy, mom receives Axenfeld-Rieger diagnosis
I Learned the Truth About My Son—But Love Never Changed
I Learned the Truth About My Son—But Love Never Changed

Neurologists verifying a reversal also look beyond the rating scale. They review pulmonary function tests, manual muscle testing, MRI imaging, and electromyography results, and they interview caregivers about changes in daily life. When a patient's strength, breathing, and imaging all point in the same direction over many months, the case becomes harder to dismiss as measurement error or placebo effect.

How Rare Are These Cases?

Data from Duke's large patient database give a sense of scale. In a study published in Neurology in 2016, Bedlack and colleagues reviewed records from more than 2,400 patients and found that roughly two percent experienced a sustained plateau, while fewer than one percent met the stricter criteria for a reversal. That works out to roughly one in a few hundred people, which is rare but far from zero.

AD

Rarity does not make these cases unimportant. Researchers treat them as natural experiments, asking what is biologically different about the people who improve. The ALS Reversals project, coordinated through Duke, collects medical records, surveys, imaging, and biological samples from patients who have plateaued or improved, building a dataset that would be impossible to assemble in a conventional clinical trial.

1.4K reactions · 49 comments | They said I’d never walk again but i’m proving them wrong! 😱👀💪 #fyp #viralreels #inspiration #recovery #paraplegic #glowup | Bellawillwalkagain | Facebook
1.4K reactions · 49 comments | They said I’d never walk again but i’m proving them wrong! 😱👀💪 #fyp #viralreels #inspiration #recovery #paraplegic #glowup | Bellawillwalkagain | Facebook
There are moments in life that divide your story into a “before” and an “after.” For us, it was the day we heard the words, “Your baby has spina bifida.” Everything suddenly felt uncertain. Questions replaced excitement. Fear crept into places hope had once lived. But even though our world felt like it had changed in an instant, one thing hadn’t. God already knew our daughter. Her diagnosis didn’t surprise Him, and it didn’t change her worth. This is the beginning of our story, and one... Spina Bifida Awareness, Spina Bifida, Motherhood Journey, First Step, His Hands, Looking Back, Medical, In This Moment
There are moments in life that divide your story into a “before” and an “after.” For us, it was the day we heard the words, “Your baby has spina bifida.” Everything suddenly felt uncertain. Questions replaced excitement. Fear crept into places hope had once lived. But even though our world felt like it had changed in an instant, one thing hadn’t. God already knew our daughter. Her diagnosis didn’t surprise Him, and it didn’t change her worth. This is the beginning of our story, and one... Spina Bifida Awareness, Spina Bifida, Motherhood Journey, First Step, His Hands, Looking Back, Medical, In This Moment
The compelling tale of a boy rejected by society due to birth defects yet rising above adversity.
The compelling tale of a boy rejected by society due to birth defects yet rising above adversity.
Facebook
Facebook
My Brother Shoved Me as a ‘Joke’ — The MRI Revealed Something Far Worse Than a Fall
My Brother Shoved Me as a ‘Joke’ — The MRI Revealed Something Far Worse Than a Fall
I'm an ER Doctor. An Unconscious Kid Was Brought In. It Was My Daughter But When I Saw...
I'm an ER Doctor. An Unconscious Kid Was Brought In. It Was My Daughter But When I Saw...

Documented ALS Reversal Stories That Shaped the Conversation

A handful of reversal stories have become reference points in the ALS community because they were documented publicly and followed over years. These cases did not emerge from anonymous internet testimonials; they involved academic medical centers, clinical trial protocols, and physicians willing to publish what they observed. Their details matter as much as their headlines.

Many more reversals exist only as de-identified records inside research registries. Some patients choose privacy, others worry about being pressured to explain or repeat whatever they did. The result is a field with a small number of famous names and a larger, quieter body of evidence that researchers are still piecing together.

AD

Ted Harada: The Case That Made National News

Ted Harada was a thirty-eight-year-old father of three and a UPS manager in Georgia when he was diagnosed with ALS in 2010. His decline was rapid: within months he was using a cane, then a wheelchair, and he struggled to lift his arms. He enrolled in an early-phase Neuralstem trial at Emory University that involved injecting fetal-derived neural stem cells directly into the spinal cord, a procedure that carried real surgical risk.

I was already told once by an ALS community, veiled in sympathy and contrition, that I was not suffering visibly enough, openly enough, or progressing fast enough from this disease to roll with them, stranger...there was more of them than there is of you... And I got over that rejection and critique...whaddya know?! The years of therapy to unpick people pleasing worked! For me, that niche is saturated by far better, far more knowledgeable, far more reliable, far more sincere people who have... Get Over It, Disease
I was already told once by an ALS community, veiled in sympathy and contrition, that I was not suffering visibly enough, openly enough, or progressing fast enough from this disease to roll with them, stranger...there was more of them than there is of you... And I got over that rejection and critique...whaddya know?! The years of therapy to unpick people pleasing worked! For me, that niche is saturated by far better, far more knowledgeable, far more reliable, far more sincere people who have... Get Over It, Disease
.... our lives are lies... what else is new?
.... our lives are lies... what else is new?
Good News!
Good News!
ALS Stages and Progression
ALS Stages and Progression

In the months that followed, Harada regained strength. He walked again, returned to work, traveled to Washington to advocate for research funding, and eventually completed a five-kilometer walk. His scans showed no new damage, and his functional scores improved dramatically. Roughly two years later, his decline resumed, and he participated in additional trials before dying in 2017. His story demonstrated two things at once: improvement is possible, and it is not always permanent.

Patterns Researchers Have Noticed in the Duke Registry

Across dozens of documented cases, certain features appear more often than chance would predict. Reversals tend to cluster among people with limb-onset disease rather than bulbar-onset disease, among younger patients, and among those whose initial progression was unusually slow. Several patients had signs of immune or inflammatory activity in their spinal fluid or blood work.

AD

Investigators have also identified what they call triggers. In some cases, improvement began after a serious infection, after starting an immune-modulating medication, or after stopping a drug for an unrelated condition. In other cases, no trigger is identifiable at all, which is precisely why the registry continues to grow. The honest scientific position is that no single explanation currently fits every case.

Why Some People Improve: The Leading Scientific Theories

ALS is increasingly understood as an umbrella term covering what may be several distinct biological processes that produce similar damage to motor neurons. If a subgroup of patients has an immune-driven or inflammatory form of the disease, then suppressing that process could plausibly produce rapid and dramatic functional improvement, at least temporarily.

A second line of thinking focuses on genetics. Roughly ten percent of ALS cases are clearly inherited, and another substantial fraction involves genes that influence risk. When a specific genetic cause is identified, researchers can design treatments that hit that target directly, which is where the most encouraging recent developments have emerged.

Immune and Inflammatory Mechanisms

The immune system plays a complicated dual role in ALS. Microglia and astrocytes can release inflammatory signals that harm motor neurons, while regulatory T cells appear to be protective, and their numbers often drop as the disease progresses. Several reversal cases involved patients whose immune profiles looked abnormal in ways that suggested an autoimmune component rather than a purely degenerative one.

Clinical trials targeting inflammation have produced mixed results at best. A Phase 2 trial of the macrophage-modulating drug NP001 failed its primary endpoint overall, though a subgroup showed signals that investigators wanted to pursue further. Low-dose interleukin-2 therapy aimed at boosting regulatory T cells has shown encouraging biological effects and is being studied in larger trials. Immune modulation remains one of the most plausible explanations for genuine reversals, but it has not yet produced a reliable treatment.

Genetic Targets and Precision Medicine

The clearest example of targeted ALS therapy to date is tofersen, an antisense oligonucleotide approved in 2023 for people with mutations in the SOD1 gene. In trials it sharply reduced levels of the toxic SOD1 protein and dramatically lowered neurofilament light chain, a marker of nerve damage in the blood. Some patients showed slowing of decline, and a subset appeared to stabilize or improve.

Tofersen is not a reversal for the general ALS population, and it comes with serious potential side effects that require monitoring. Still, it proves a principle: when you know the precise cause, you can intervene in ways that change the disease's trajectory. Similar programs are underway for C9orf72, FUS, and ATXN2, and many researchers believe future reversals will come from this kind of targeted biology rather than broad wellness protocols.

Lifestyle, Metabolism, and the Question of Vitality

Registry surveys show that people who experience reversals often report unusual habits: strict diets, extensive supplement regimens, intense exercise, meditation, sauna use, and strong social or spiritual support. These accounts are compelling, but they come with a built-in problem. Nobody knows whether those behaviors caused the improvement, resulted from feeling better, or simply reflect the kind of person who pursues every possible option.

Metabolism is a genuinely promising area of research. Many people with ALS are hypermetabolic and lose weight rapidly, and poor nutritional status correlates with faster progression. Studies of ketogenic diets, high-calorie supplementation, and metabolic drugs are ongoing. What does not yet exist is credible evidence that any single supplement or diet reliably reverses ALS, and families should be deeply skeptical of anyone selling one.

When a "Reversal" Is Really a Misdiagnosis

Some of the most dramatic recovery stories in circulation are not reversals of ALS at all. They are cases of a different disease being mistaken for ALS and then treated successfully. Neuromuscular specialists estimate that somewhere between five and ten percent of ALS diagnoses are later revised, and the number is higher when the initial evaluation happens outside a dedicated ALS center.

This is not a failure of modern medicine so much as a reflection of how difficult motor neuron disease is to diagnose. There is no single confirmatory blood test. Diagnosis relies on clinical examination, electromyography, imaging, and the exclusion of dozens of other conditions, some of which are rare and some of which mimic ALS almost perfectly in their early stages.

Conditions Frequently Mistaken for ALS

Certain disorders share the hallmark combination of progressive weakness, muscle wasting, and brisk reflexes. Several of them are treatable, sometimes fully, which is why an accurate diagnosis is the first and most important step before any discussion of reversal.

  • Multifocal motor neuropathy, an immune-mediated condition that responds to intravenous immunoglobulin in many patients.
  • Chronic inflammatory demyelinating polyneuropathy, which can cause progressive weakness and responds to immune therapies.
  • Spinal dural arteriovenous fistula, a treatable vascular abnormality that can cause steadily worsening leg weakness and bladder problems.
  • Cervical spondylotic myelopathy, where compression of the spinal cord produces hand weakness and gait changes.
  • Copper deficiency and vitamin B12 deficiency, both of which can produce a myeloneuropathy resembling ALS.
  • Heavy metal toxicity, including lead and mercury exposure.
  • Adult-onset spinal muscular atrophy, Kennedy's disease, and hereditary spastic paraplegia, all genetic conditions with overlapping features.
  • Paraneoplastic motor neuron syndromes, which occasionally improve when an underlying cancer is treated.

Each of these has its own diagnostic clues, and each is worth ruling out before accepting a final ALS diagnosis, especially when the presentation is atypical.

Why a Second Opinion Changes Outcomes

Being evaluated at an ALS Association Certified Treatment Center of Excellence or a comparable multidisciplinary clinic substantially increases the odds of an accurate diagnosis. These centers see hundreds of cases per year, use neuromuscular specialists to interpret electromyography, and have access to genetic testing and clinical trials that community practices often cannot offer.

Patients who receive a diagnosis that does not quite fit should ask direct questions. Is the progression unusually fast or unusually slow? Is there sensory involvement, which is atypical for ALS? Did the electromyography show changes in the expected pattern? If a treatable mimic is on the differential, a supervised trial of therapy, such as immunoglobulin for multifocal motor neuropathy, can sometimes answer the question within weeks.

Approaching Reversal Stories With Open Eyes

Hope is not a weakness in ALS care; it is part of what keeps people engaged in treatment, research, and life. The challenge is holding hope alongside rigor, especially in an online landscape where dramatic claims spread faster than peer review. Families deserve both compassion and accurate information.

A useful habit is to ask what kind of evidence sits behind any story. A single testimonial is a data point, not a finding. A published case series with objective measurements over a year or more is far stronger. A randomized controlled trial is stronger still, though in ALS these take years and cost millions of dollars.

Separating Hope From Hype

Several red flags reliably signal that a claimed reversal is being marketed rather than studied. Anyone guaranteeing an outcome, requiring large upfront payments, refusing to share protocols with physicians, or discouraging patients from continuing standard care should be treated with caution. Unregulated stem cell clinics in particular have caused serious harm, including deaths from injected cell preparations that were never approved for human use.

Reliable resources exist for sorting through claims. ALS Untangled publishes systematic reviews of alternative and off-label treatments. ClinicalTrials.gov lists ongoing studies with eligibility criteria. A neurologist at a certified ALS center can usually tell within minutes whether a promoted protocol has any supporting data behind it.

How Patients Can Contribute to Real Progress

People living with ALS have more power to advance the science than they sometimes realize. The Duke ALS Reversals registry actively recruits anyone who has plateaued or improved, regardless of what they think caused it. The CDC's National ALS Registry collects epidemiological data, and efforts like Answer ALS and Target ALS build open-access datasets from thousands of participants.

Donating blood, spinal fluid, and eventually tissue makes a permanent difference. Ted Harada's autopsy contributed valuable information about what happens in the spinal cord after stem cell transplantation, information that no one could have obtained any other way. Participating in trials, even unsuccessful ones, moves the field forward because every result narrows the search.

The stories of people who improve against expectation are worth telling carefully, without exaggeration and without dismissal. They point toward a future in which ALS is understood not as one uniform disease but as a collection of conditions with different causes and different responses to treatment. If you or someone you love is navigating this diagnosis, the most valuable action is also the least dramatic: get expert evaluation, ask hard questions, and consider joining the research that will eventually explain these reversals rather than merely celebrating them.

AD